HIA
UTHR icon

HFM Investment Advisors’s United Therapeutics UTHR Stock Holding History

HFM Investment Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.33K Buy
8
+5
+167% +$2.82K ﹤0.01% 221
2026
Q1 		$1.78K Hold
3
– – ﹤0.01% 252
2025
Q4 		$1.46K Hold
3
– – ﹤0.01% 352
2025
Q3 		$1.26K Hold
3
– – ﹤0.01% 287
2025
Q2 		$862 Buy
3
+1
+50% +$299 ﹤0.01% 433
2025
Q1 		$617 Buy
+2
New +$685 ﹤0.01% 240

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

HFM Investment Advisors's UTHR Position: Q2 2026 in Review

HFM Investment Advisors increased its United Therapeutics (UTHR) stake by 167% in Q2 2026, buying an estimated $2.82K and bringing the position to 8 shares worth $4.33K. The position accounts for ﹤0.01% of the portfolio, ranked #221.

HFM Investment Advisors first reported a position in UTHR in Q1 2025 and has held it in 6 quarters since. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • HFM Investment Advisors held 8 shares of United Therapeutics worth $4.33K as of Q2 2026.
  • HFM Investment Advisors bought 5 United Therapeutics shares in Q2 2026, an estimated $2.82K.
  • United Therapeutics made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #221 holding.
  • HFM Investment Advisors first reported a position in United Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.